Brexpiprazole for schizophrenia and as adjunct for major depressive disorder

Adjunctive treatment of brexpiprazole with fluoxetine shows a rapid antidepressant effect in social defeat stress model: Role of BDNF-TrkB signaling

Life, Free Full-Text

Brexpiprazole in the Treatment of Major Depressive Disorder - Maryam I Al Shirawi, Nicole E Edgar, Sidney H Kennedy, 2017

Frontiers Brexpiprazole in patients with schizophrenia with or without substance use disorder: an observational study

PDF) Spotlight on brexpiprazole and its potential in the treatment of schizophrenia and as adjunctive therapy for the treatment of major depression

Spotlight on brexpiprazole and its potential in the treatment of schizophrenia and as adjunctive therapy for the treatment of major depression. - Abstract - Europe PMC

Psychopharmacology Update - ppt download

Brexpiprazole Short-Term Clinical Study Designs for the Adjunctive

Brexpiprazole in the Treatment of Major Depressive Disorder - Maryam I Al Shirawi, Nicole E Edgar, Sidney H Kennedy, 2017

Brexpiprazole - Mechanism of Action and Clinical Application

Effects of adjunctive brexpiprazole on patient life engagement in major depressive disorder: Post hoc analysis of Inventory of Depressive Symptomatology Self-Report data - ScienceDirect

PDF) Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: an exploratory study

Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study